Key result
ACE II genotype is linked to ~97% higher lung cancer risk, compounded by tobacco use.
Why the study?
Does the ACE II genotype and its interaction with tobacco use increase the risk of lung cancer in a high-risk population from Northeast India?
Case-Control (n=302)
Yes
Does the ACE II genotype and its interaction with tobacco use increase the risk of lung cancer in a high-risk population from Northeast India?
The ACE II genotype, especially in combination with tobacco smoking or chewing, is significantly associated with an increased risk of lung cancer in the Northeast Indian population.
ACE II genotype may modify lung cancer susceptibility with tobacco in Northeast India; hypothesis-generating and should not yet guide risk stratification or screening.
BACKGROUND: Association of angiotensin converting enzyme (ACE) gene polymorphisms with lung cancer susceptibility remains uncertain and varies with ethnicity. Northeast India represents a geographically, culturally, and ethnically isolated population. The area reports an especially high rate of tobacco usage in a variety of ways of consumption, compared with the rest of the Indian population. MATERIALS AND METHODS: We conducted a population based case control study in two major high risk region for lung cancer from Northeast India. A total of 151 consecutive lung cancer cases diagnosed histopathologically and equal numbers of controls were recruited with record of relevant sociodemographic information. Blood samples were collected and processed to identify ACE gene polymorphism. RESULTS: Significantly higher (40.4 % vs 29.1%, OR=1.97, CI=1.04-3.72; p=0.037) prevalence of the ACE II genotype was observed among lung cancer cases. Smoking was significantly associated with increased risk of lung cancer (OR=1.70, CI=1.02-2.81; p=0.041). An enhanced risk was also observed for interaction of ACE II genotype with tobacco smoking (OR=4.09, CI=1.51-11.05; p=0.005) and chewing (OR=3.68, CI=1.22-11.13; p=0.021). CONCLUSIONS: The present study indicates significant association s of the ACE II genotype with lung cancer in high risk Northeast India.
No takes yet. Share an insight, caveat, or question.
Phukan et al. (2015) conducted a case-control in Lung cancer (n=302). ACE II genotype vs. ACE DD genotype / Controls was evaluated on Prevalence of ACE II genotype and risk of lung cancer (OR 1.97, 95% CI 1.04-3.72, p=0.037). The ACE II genotype was associated with a significantly increased risk of lung cancer compared to controls (OR 1.97), which was further enhanced by interaction with tobacco smoking and chewing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: